Pii (Pharmaceutics International, Inc.), acquired by Jabil in February 2025, is a US-based CDMO specializing in complex formulations. With over 30 years of experience and 300+ scientists and support staff, Pii handles potent compounds, complex formulations, aseptic injectables, complex oral dosage forms, and high-potency soft gels. Offers phase-appropriate support from early development through commercial manufacturing. Located in Hunt Valley, Maryland. 100% FDA licensed with 5 drug product approvals in 2023.
Complex formulations, high-potency compound handling, aseptic injectable manufacturing, lyophilization, prefilled syringe filling, oral solid dose, soft gel manufacturing, oxygen-sensitive drug products
2 sites worldwide
No reviews available yet.
No documents available.